Medifast (MED)
Your Dashboard
Displaying MED Charts
Personalize your Dashboard. You can add and remove charts, drag and drop them into the order you
like, and we'll save your settings for the next time you visit when you're logged in.
Log in here or Click here to register for your free account.
Select or add more charts
- Accounts Payable 26.16M
- Accounts Receivable 2.177M
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization 2.855
- Beneish M-Score Pro
- Beta Pro
- Book Value 78.10M
- Book Value per Share 5.036
- Capital Expenditures 2.492M
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing -0.266M
- Cash Financing TTM -21.42M
- Cash Investing -2.769M
- Cash Investing TTM -14.66M
- Cash Operations 20.71M
- Cash Operations TTM 36.83M
- Cash and Equivalents 31.94M
- Cash and ST Investments 51.99M
- Current Ratio 2.760
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio 0.0692
- Dividend
- Dividend Yield 0.00%
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share 0.29
- Earnings Per Share Growth -34.09%
- Earnings Per Share TTM 1.16
- Earnings Yield 6.42%
- Effective Tax Rate TTM Pro
- Enterprise Value 253.74M
- Expenses 84.93M
- Expenses TTM 296.64M
- Free Cash Flow 18.22M
- Free Cash Flow TTM 23.15M
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin 75.07%
- Gross Profit TTM 234.57M
- Income from Cont. Ops Pro
- Interest Expense 0.00
- Interest Income 0.073M
- Inventories 15.35M
- KZ Index Pro
- Liabilities 39.16M
- Long Term Debt 5.407M
- Market Cap 280.27M
- Net Income 3.99M
- Net Income TTM 16.17M
- Net PP&E 39.19M
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio 15.58
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price 18.07
- Price / Book Value 3.588
- Price / Sales Ratio 0.8959
- Price / Tangible Book Value Pro
- Profit Margin 4.49%
- R&D Expense
- Receivables Turnover 218.45
- Retained Earnings 64.65M
- Retained Earnings Growth 33.36%
- Return on Assets 15.15%
- Return on Equity 21.48%
- Return on Invested Capital Pro
- Revenue Growth 19.69%
- Revenue Per Share TTM 20.17
- Revenues 88.92M
- Revenues TTM 312.82M
- SG&A Expense 60.62M
- Shareholders Equity 78.10M
- Shares Outstanding 15.51M
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets 117.26M
- Total Return Price 18.07
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
What do these terms mean? Read all about them in the Glossary.
You may also be interested in these MED related companies
MED News
$MED purchased 150,000 shares of its common this week at cost basis of $18.34 http://stks.co/3zoW
about 5 days ago by WallStreetBean
about 5 days ago by WallStreetBean
$VVUS still long 2/3 sadly wt loss & diabetes drugs a growth industry. watch techncls for timing tho. $HLF $WTW $MED are done imho,
about 18 days ago by TrendHunter
about 18 days ago by TrendHunter
$HLF $WTW should get more down pressure with $ARNA approval imho. These remain as shorts. $MED is an oddity, perhaps just a short sqz
about 20 days ago by TrendHunter
about 20 days ago by TrendHunter
Auriga Reiterates a 'Buy' on Medifast (MED); Still Like Long-Term, But Cutting Estimates on Mixed Results
May 09, 10:47AM Street Insider
May 09, 10:47AM Street Insider
Mercadolibre, Gulfport Energy Corporation Among Stocks Gapping Down Wednesday
May 09, 10:31AM Fox Business
May 09, 10:31AM Fox Business
$MED is 6.1% up since open on unusual high volume but still -7.6% down since close.
about 22 days ago by TradeBot
about 22 days ago by TradeBot
$MED 200 Day SMA Cross - Price crossed below 200 day SMA (16.4047). Confirmed by volume.
about 22 days ago by TradeIdeasQuant
about 22 days ago by TradeIdeasQuant
Listen to $MED Q1 2012 earnings call - live at 04:30 PM, ondemand after - http://stks.co/3jHT
about 22 days ago by earningscast
about 22 days ago by earningscast
$MED i will risk it. With new MGM i believe that might want to prove something as well. Odds seem good.
about 23 days ago by nobr3ga
about 23 days ago by nobr3ga
@nobr3ga $MED fundies look really good to me going into EPS, but....will they look good coming out? That's the ?
about 23 days ago by WallStreetBean
about 23 days ago by WallStreetBean
@WallStreetBean $MED has a good 50% retracement. $HLF had a great Q, but were pyramid scheme operations. With regards to $WTW I dnt know
about 23 days ago by nobr3ga
about 23 days ago by nobr3ga
@nobr3ga been long $MED for a while but feeling a bit squeamish in light of recent Q's from $HLF and $WTW. Maybe they will break trend.
about 23 days ago by WallStreetBean
about 23 days ago by WallStreetBean
Competitor $MED reports 5/8. Keep Einhorn away! RT @harmongreg It may be time to give Herb a new Life, if you know what I mean $$
about 25 days ago by WallStreetBean
about 25 days ago by WallStreetBean
$HLF $WTW $MED seems like trading community thinks drugs $VVUS etc are the wt loss future. The American way, dont have self cntrl use drugs.
about 28 days ago by TrendHunter
about 28 days ago by TrendHunter
Surprised $MED held up as well as it did today after $HLF's punishment.
about 29 days ago by WallStreetBean
about 29 days ago by WallStreetBean
Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2012
Apr 24, 4:05PM PR Newswire
Apr 24, 4:05PM PR Newswire
$MED more than 20% float is short with about 12 days to cover. Bloodsport.
about 43 days ago by WallStreetBean
about 43 days ago by WallStreetBean
Medifast continues to make investors fat. $MED number 10 overall today. Great Chart.
about 44 days ago by billgunderson
about 44 days ago by billgunderson
Canaccord Genuity Maintains a 'Buy' on Medifast (MED); Limited Downside, But Waiting For Clarity To Upside
Apr 10, 9:51AM Street Insider
Apr 10, 9:51AM Street Insider
don't know why but not complaining. RT @bricktop13 $MED breaking out of an 8-month base.
about 59 days ago by WallStreetBean
about 59 days ago by WallStreetBean
Auriga Reiterates a 'Buy' on Medifast (MED), but Cutting Numbers on Growing Pains
Mar 14, 1:47PM Street Insider
Mar 14, 1:47PM Street Insider
Wedbush Maintains an 'Outperform' on Medifast (MED); Mixed Q4; Raising Estimates on Accelerating Outlook
Mar 14, 1:17PM Street Insider
Mar 14, 1:17PM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MED | 18.07 | -0.79 | -4.19% | 280.27M |
| MEAS | 32.91 | -0.63 | -1.88% | 503.77M |
| MEAD | 3.54 | +0.00 | +0.00% | 4.354M |
| MAXY | 5.81 | -0.06 | -1.02% | 163.01M |
| MAV | 15.16 | +0.00 | +0.00% | |
| MATW | 29.98 | -0.49 | -1.61% | 864.43M |
| MATR | 6.93 | -0.06 | -0.86% | 117.29M |
| MAT | 31.17 | -0.34 | -1.08% | 10.68B |
| MASC | 8.05 | -0.05 | -0.62% | 85.37M |
| MAS | 12.36 | -0.64 | -4.92% | 4.645B |
